Immunovia AB Stock OTC Markets
Stocks
IMMVF
SE0006091997
Advanced Medical Equipment & Technology
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.000 USD | -48.56% |
|
+9,900.00% | +9,900.00% |
| 06-15 | Immunovia Unveils New Data Ahead of Medicare Reimbursement Application | FW |
| 06-15 | Immunovia Announces New Performance Data for PancreaSure Ahead of Upcoming Application for Medicare Coverage | CI |
| Market Cap | 128M 13.19M 11.54M 10.65M 9.94M 18.73M 1.25B 19.06M 49.62M 615M 49.54M 48.44M 2.14B | P/E 2026 * |
-1.9x | P/E 2027 * | -4.75x |
|---|---|---|---|---|---|
| Enterprise Value | 60.81M 6.27M 5.49M 5.07M 4.73M 8.91M 593M 9.07M 23.61M 293M 23.57M 23.04M 1.02B | EV / Sales 2026 * |
19x | EV / Sales 2027 * | 3.11x |
| Free-Float |
89.3% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Immunovia AB
| 1 day | -48.56% | ||
| 1 week | +9,900.00% | ||
| Current month | +9,900.00% | ||
| 1 month | +9,900.00% | ||
| 3 months | +9,900.00% | ||
| 6 months | +3,900.00% | ||
| Current year | +9,900.00% |
| 1 year | 0.02 |  | 0.02 |
| 3 years | 0.02 | | 0.17 |
| 5 years | 0.02 | | 40 |
| 10 years | 0.02 | | 40 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jeff Borcherding
CEO | Chief Executive Officer | 53 | 2023-04-28 |
Lisa Ford
CTO | Chief Tech/Sci/R&D Officer | 55 | 2024-04-28 |
| Chief Tech/Sci/R&D Officer | 54 | 2024-01-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 72 | 2016-12-08 | |
Peter Andersen
CHM | Chairman | 69 | 2023-05-25 |
| Director/Board Member | 51 | 2020-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -48.56% | +9,900.00% | - | - | 13.14M | |
| +2.55% | +7.95% | +6.30% | -27.59% | 16.13B | |
| +0.28% | -3.16% | +24.70% | +71.35% | 1.51B | |
| 0.00% | -1.74% | -32.78% | +25.92% | 1.09B | |
| -3.32% | +48.05% | -38.69% | -78.67% | 1.24B | |
| -2.82% | -10.32% | -26.14% | -54.57% | 629M | |
| -2.03% | +0.34% | -36.87% | -57.44% | 594M | |
| -0.60% | -5.61% | +14.53% | -57.87% | 421M | |
| -2.09% | -3.17% | -55.96% | -61.54% | 379M | |
| +0.59% | -1.59% | -25.08% | -25.82% | 332M | |
| Average | -5.69% | +3.47% | -18.89% | -29.58% | 2.48B | |
| Weighted average by Cap. | +1.48% | +5.52% | -0.31% | -23.82% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.2M 330K 289K 267K 249K 469K 31.22M 477K 1.24M 15.4M 1.24M 1.21M 53.67M | 17.3M 1.78M 1.56M 1.44M 1.35M 2.53M 169M 2.58M 6.72M 83.28M 6.71M 6.56M 290M |
| Net income | -91M -9.39M -8.22M -7.59M -7.08M -13.33M -888M -13.57M -35.33M -438M -35.28M -34.49M -1.53B | -82M -8.46M -7.41M -6.84M -6.38M -12.01M -800M -12.23M -31.83M -395M -31.79M -31.08M -1.38B |
| Net Debt | -67M -6.91M -6.05M -5.59M -5.21M -9.82M -654M -9.99M -26.01M -323M -25.97M -25.39M -1.12B | -74M -7.64M -6.68M -6.17M -5.75M -10.84M -722M -11.04M -28.73M -356M -28.69M -28.04M -1.24B |
Employees
17
Calendar
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IMMNOV Stock
- IMMVF Stock
Select your edition
All financial news and data tailored to specific country editions
